Cargando…

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

The objectives of the study were to assess the relationship between the serum levels of MMP-9 and NGAL and the clinical staging and histopathological grade of the tumor. Lipocalin-2/NGAL and MMP-9 concentrations were quantified in serum by multiplex fluorescent bead-based immunoassays (Luminex Corpo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cymbaluk-Płoska, Aneta, Chudecka-Głaz, Anita, Pius-Sadowska, Ewa, Sompolska-Rzechuła, Agnieszka, Chudecka, Karolina, Bulsa, Michał, Machaliński, Bogusław, Menkiszak, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635290/ https://www.ncbi.nlm.nih.gov/pubmed/29089666 http://dx.doi.org/10.1155/2017/6589262

Ejemplares similares

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2017)

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
por: Chudecka-Głaz, Anita Monika, et al.
Publicado: (2015)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Risk Model in Women with Ovarian Cancer Without Mutations
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2014)

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2017)

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2018)

Ectopic pregnancy treatment by combination therapy
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2016)

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
por: Chudecka-Głaz, Anita Monika, et al.
Publicado: (2014)

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023)

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department – the follow-up at 1 year
por: Nikodemski, Tomasz, et al.
Publicado: (2017)

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
por: Pietrzyk, Dominika, et al.
Publicado: (2023)

Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
por: Menkiszak, Janusz, et al.
Publicado: (2016)

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
por: Menkiszak, Janusz, et al.
Publicado: (2019)

Evaluation of the Concentration of Selected Elements in Patients with Cancer of the Reproductive Organs with Respect to Treatment Stage—Preliminary Study
por: Wieder-Huszla, Sylwia, et al.
Publicado: (2022)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)

Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)

Anxiety Assessment in Polish Students during the Russian–Ukrainian War
por: Skwirczyńska, Edyta, et al.
Publicado: (2022)

Endometrial Cancer Management in Young Women
por: Markowska, Anna, et al.
Publicado: (2022)

Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors
por: Chudecka-Głaz, Anita, et al.
Publicado: (2013)

The Clinical Importance of IL-6, IL-8, and TNF-α in Patients with Ovarian Carcinoma and Benign Cystic Lesions
por: Pawlik, Weronika, et al.
Publicado: (2021)

Pleiotropic activity of nerve growth factor in regulating cardiac functions and counteracting pathogenesis
por: Pius‐Sadowska, Ewa, et al.
Publicado: (2021)

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population
por: Mędrek, Krzysztof, et al.
Publicado: (2012)

Can Adjuvant HPV Vaccination Be Helpful in the Prevention of Persistent/Recurrent Cervical Dysplasia after Surgical Treatment?—A Literature Review
por: Michalczyk, Kaja, et al.
Publicado: (2022)

Metalloproteinases in Endometrial Cancer—Are They Worth Measuring?
por: Michalczyk, Kaja, et al.
Publicado: (2021)

Renal and Inflammation Markers—Renalase, Cystatin C, and NGAL Levels in Asymptomatic and Symptomatic SARS-CoV-2 Infection in a One-Month Follow-Up Study
por: Serwin, Natalia, et al.
Publicado: (2022)

The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma (2023)
por: Sznurkowski, Jacek J., et al.
Publicado: (2023)

The Influence of Biologically Active Substances Secreted by the Adipose Tissue on Endometrial Cancer
por: Michalczyk, Kaja, et al.
Publicado: (2021)

The Significance of Adaptation and Coping with Disease among Patients with Diagnosed Gynaecological Cancer in the Context of Disease Acceptance
por: Wieder-Huszla, Sylwia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i4fsh59avhvu7vgaun6fnmjakl